A method for treating a pulmonary hypertension condition such as pulmonary arterial hypertension(PAH) in a subject comprises administering to the subject a therapeutically effectiveamount of ambrisentan, wherein, at baseline, time from first diagnosis of thecondition in the subject is not greater than about 2 years.